Search Results - "Brunham, L."

Refine Results
  1. 1

    Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice by Kruit, J. K, Kremer, P. H. C, Dai, L, Tang, R, Ruddle, P, de Haan, W, Brunham, L. R, Verchere, C. B, Hayden, M. R

    Published in Diabetologia (01-06-2010)
    “…Aims/hypothesis Cellular cholesterol accumulation is an emerging mechanism for beta cell dysfunction in type 2 diabetes. Absence of the cholesterol transporter…”
    Get full text
    Journal Article
  2. 2

    Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin by Brunham, L R, Lansberg, P J, Zhang, L, Miao, F, Carter, C, Hovingh, G K, Visscher, H, Jukema, J W, Stalenhoef, A F, Ross, C J D, Carleton, B C, Kastelein, J J P, Hayden, M R

    Published in The pharmacogenomics journal (01-06-2012)
    “…Statins reduce cardiovascular morbidity and mortality in appropriately selected patients. However, statin-associated myopathy is a significant risk associated…”
    Get full text
    Journal Article
  3. 3

    Development and Validation of Algorithms for the Detection of Statin Myopathy Signals From Electronic Medical Records by Chan, SL, Tham, MY, Tan, SH, Loke, C, Foo, BPQ, Fan, Y, Ang, PS, Brunham, LR, Sung, C

    Published in Clinical pharmacology and therapeutics (01-05-2017)
    “…The purpose of this study was to develop and validate sensitive algorithms to detect hospitalized statin‐induced myopathy (SIM) cases from electronic medical…”
    Get full text
    Journal Article
  4. 4

    Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans by Brunham, LR, Tietjen, I, Bochem, AE, Singaraja, RR, Franchini, PL, Radomski, C, Mattice, M, Legendre, A, Hovingh, GK, Kastelein, JJP, Hayden, MR

    Published in Clinical genetics (01-06-2011)
    “…Brunham LR, Tietjen I, Bochem AE, Singaraja RR, Franchini PL, Radomski C, Mattice M, Legendre A, Hovingh GK, Kastelein JJP, Hayden MR. Novel mutations in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent by Aminkeng, F, Ross, C J D, Rassekh, S R, Brunham, L R, Sistonen, J, Dube, M-P, Ibrahim, M, Nyambo, T B, Omar, S A, Froment, A, Bodo, J-M, Tishkoff, S, Carleton, B C, Hayden, M R

    Published in The pharmacogenomics journal (01-04-2014)
    “…There is established clinical evidence for differences in drug response, cure rates and survival outcomes between different ethnic populations, but the causes…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Intestinal ABCA1 directly contributes to HDL biogenesis in vivo by Brunham, Liam R, Kruit, Janine K, Iqbal, Jahangir, Fievet, Catherine, Timmins, Jenelle M, Pape, Terry D, Coburn, Bryan A, Bissada, Nagat, Staels, Bart, Groen, Albert K, Hussain, M Mahmood, Parks, John S, Kuipers, Folkert, Hayden, Michael R

    Published in The Journal of clinical investigation (01-04-2006)
    “…Plasma HDL cholesterol levels are inversely related to risk for atherosclerosis. The ATP-binding cassette, subfamily A, member 1 (ABCA1) mediates the…”
    Get full text
    Journal Article
  10. 10

    Pharmacogenomic diversity in Singaporean populations and Europeans by Brunham, L R, Chan, S L, Li, R, Aminkeng, F, Liu, X, Saw, W Y, Ong, R T H, Pillai, E N, Carleton, B C, Toh, D, Tan, S H, Koo, S H, Lee, E J D, Chia, K S, Ross, C J D, Hayden, M R, Sung, C, Teo, Y Y

    Published in The pharmacogenomics journal (01-12-2014)
    “…Differences in the frequency of pharmacogenomic variants may influence inter-population variability in drug efficacy and risk of adverse drug reactions (ADRs)…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Efflux and Atherosclerosis: The Clinical and Biochemical Impact of Variations in the ABCA1 Gene by Singaraja, Roshni R, Brunham, Liam R, Visscher, Henk, Kastelein, John J.P, Hayden, Michael R

    “…Approximately 50 mutations and many single nucleotide polymorphisms have been described in the ABCA1 gene, with mutations leading to Tangier disease and…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Cilia get serious: Meckel-Gruber and Bardet-Biedl syndromes represent a spectrum of allelic disorders by Brunham, LR

    Published in Clinical genetics (01-01-2009)
    “…Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet‐Biedl syndrome
Leitch et al. (2008)
Nature Genetics 40: 443–448…”
    Get full text
    Journal Article
  17. 17

    LeaPIN' toward the cause of myoglobinuria in childhood by Brunham, LR

    Published in Clinical genetics (01-01-2009)
    “…Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood
Zeharia et al. (2008)
The American Journal of Human Genetics 83: 1–6…”
    Get full text
    Journal Article
  18. 18

    ALAS, our frailty is the cause ... of a new for form of protoporphyria by Brunham, LR

    Published in Clinical genetics (01-01-2009)
    “…C‐terminal deletions in the ALAS2 gene lead to gain of function and cause X‐linked dominant protoporphyria without anemia or iron overload
Whatley et al…”
    Get full text
    Journal Article
  19. 19
  20. 20

    SCREENING FOR INHERITED DYSLIPIDEMIAS AND SUBCLINICAL ATHEROSCLEROSIS IN FIRST DEGREE RELATIVES OF PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE: DIAGNOSTIC YIELD AND IMPACT ON PATIENTS MANAGEMENT by Vikulova, D, Pimstone, S, Brunham, L

    Published in Canadian journal of cardiology (01-10-2021)
    “…The screening of first-degree relatives (FDR) of patients with premature atherosclerotic cardiovascular disease (ASCVD) is recommended due to its high…”
    Get full text
    Journal Article